Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
24 Jun 24
8-K
Departure of Directors or Certain Officers
31 May 24
8-K
Departure of Directors or Certain Officers
20 May 24
10-Q
2024 Q1
Quarterly report
16 May 24
8-K
Contineum Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
16 May 24
8-K
Amendments to Articles of Incorporation or Bylaws
9 Apr 24
S-8
Registration of securities for employees
9 Apr 24
424B4
Prospectus supplement with pricing info
5 Apr 24
EFFECT
Notice of effectiveness
5 Apr 24
CERT
Certification of approval for exchange listing
4 Apr 24
8-A12B
Registration of securities on exchange
2 Apr 24
S-1/A
IPO registration (amended)
1 Apr 24
S-1
IPO registration
15 Mar 24
DRS/A
Draft registration statement (amended)
15 Feb 24
DRS/A
Draft registration statement (amended)
29 Jan 24
Latest ownership filings
4
Sarah Boyce
24 Jun 24
3
Sarah Boyce
24 Jun 24
4
John Stephen Healy
3 Jun 24
3
John Stephen Healy
3 Jun 24
4
Carmine N. Stengone
29 May 24
4
Peter T Slover
29 May 24
4
Daniel S. Lorrain
29 May 24
4
Stephen L. Huhn
29 May 24
4
Troy A. Ignelzi
29 May 24
4
Olivia C Ware
29 May 24
4
Lori Lyons-Williams
29 May 24
4
Todd R. Brady
29 May 24
4
Evert B. Schimmelpennink
29 May 24
3
Troy A. Ignelzi
20 May 24
4
Troy A. Ignelzi
20 May 24
SC 13G
SUVRETTA CAPITAL MANAGEMENT, LLC
15 Apr 24
SC 13G
PERCEPTIVE ADVISORS LLC
15 Apr 24
4
Change in insider ownership
11 Apr 24
SC 13G
JOHNSON & JOHNSON
10 Apr 24
3
& JOHNSON JOHNSON
10 Apr 24
3
Initial statement of insider ownership
4 Apr 24
3
Olivia C Ware
4 Apr 24
3
Evert B. Schimmelpennink
4 Apr 24
3
Lori Lyons-Williams
4 Apr 24
3
Todd R. Brady
4 Apr 24
3
Stephen L. Huhn
4 Apr 24
3
Peter T Slover
4 Apr 24
3
Daniel S. Lorrain
4 Apr 24
3
Carmine N. Stengone
4 Apr 24